vs
KAISER ALUMINUM CORP（KALU）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是KAISER ALUMINUM CORP的1.5倍（$1.4B vs $929.0M），瑞思迈净利率更高（27.6% vs 3.0%，领先24.6%），KAISER ALUMINUM CORP同比增速更快（21.4% vs 11.0%），瑞思迈自由现金流更多（$311.2M vs $-51.1M），过去两年KAISER ALUMINUM CORP的营收复合增速更高（12.2% vs 9.0%）
凯撒铝业是美国知名铝产品生产商，前身为凯撒铝业化工公司。其历史可追溯至Permanente Metals公司，该公司公开发行普通股后更名为凯撒铝业化工公司，后续拆分出现在的凯撒铝业，深耕铝材料生产领域，为下游多行业提供铝制品解决方案。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
KALU vs RMD — 直观对比
营收规模更大
RMD
是对方的1.5倍
$929.0M
营收增速更快
KALU
高出10.4%
11.0%
净利率更高
RMD
高出24.6%
3.0%
自由现金流更多
RMD
多$362.3M
$-51.1M
两年增速更快
KALU
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $929.0M | $1.4B |
| 净利润 | $28.2M | $392.6M |
| 毛利率 | 13.3% | 61.8% |
| 营业利润率 | 6.5% | 34.6% |
| 净利率 | 3.0% | 27.6% |
| 营收同比 | 21.4% | 11.0% |
| 净利润同比 | 42.4% | 13.9% |
| 每股收益（稀释后） | $1.67 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KALURMD
| Q4 25 | $929.0M | $1.4B | ||
| Q3 25 | $843.5M | $1.3B | ||
| Q2 25 | $823.1M | $1.3B | ||
| Q1 25 | $777.4M | $1.3B | ||
| Q4 24 | $765.4M | $1.3B | ||
| Q3 24 | $747.7M | $1.2B | ||
| Q2 24 | $773.4M | $1.2B | ||
| Q1 24 | $737.5M | $1.2B |
净利润KALURMD
| Q4 25 | $28.2M | $392.6M | ||
| Q3 25 | $39.5M | $348.5M | ||
| Q2 25 | $23.2M | $379.7M | ||
| Q1 25 | $21.6M | $365.0M | ||
| Q4 24 | $19.8M | $344.6M | ||
| Q3 24 | $8.8M | $311.4M | ||
| Q2 24 | $18.9M | $292.2M | ||
| Q1 24 | $18.2M | $300.5M |
毛利率KALURMD
| Q4 25 | 13.3% | 61.8% | ||
| Q3 25 | 13.6% | 61.5% | ||
| Q2 25 | 12.2% | 60.8% | ||
| Q1 25 | 13.4% | 59.3% | ||
| Q4 24 | 12.5% | 58.6% | ||
| Q3 24 | 9.6% | 58.6% | ||
| Q2 24 | 13.4% | 58.5% | ||
| Q1 24 | 11.7% | 57.9% |
营业利润率KALURMD
| Q4 25 | 6.5% | 34.6% | ||
| Q3 25 | 5.8% | 33.4% | ||
| Q2 25 | 4.6% | 33.7% | ||
| Q1 25 | 5.3% | 33.0% | ||
| Q4 24 | 5.0% | 32.5% | ||
| Q3 24 | 1.8% | 31.6% | ||
| Q2 24 | 4.7% | 31.2% | ||
| Q1 24 | 3.3% | 31.3% |
净利率KALURMD
| Q4 25 | 3.0% | 27.6% | ||
| Q3 25 | 4.7% | 26.1% | ||
| Q2 25 | 2.8% | 28.2% | ||
| Q1 25 | 2.8% | 28.3% | ||
| Q4 24 | 2.6% | 26.9% | ||
| Q3 24 | 1.2% | 25.4% | ||
| Q2 24 | 2.4% | 23.9% | ||
| Q1 24 | 2.5% | 25.1% |
每股收益（稀释后）KALURMD
| Q4 25 | $1.67 | $2.68 | ||
| Q3 25 | $2.38 | $2.37 | ||
| Q2 25 | $1.41 | $2.58 | ||
| Q1 25 | $1.31 | $2.48 | ||
| Q4 24 | $1.21 | $2.34 | ||
| Q3 24 | $0.54 | $2.11 | ||
| Q2 24 | $1.15 | $1.97 | ||
| Q1 24 | $1.12 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.0M | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $826.1M | $6.3B |
| 总资产 | $2.6B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资KALURMD
| Q4 25 | $7.0M | $1.4B | ||
| Q3 25 | $17.2M | $1.4B | ||
| Q2 25 | $13.1M | $1.2B | ||
| Q1 25 | $21.3M | $932.7M | ||
| Q4 24 | $18.4M | $521.9M | ||
| Q3 24 | $45.7M | $426.4M | ||
| Q2 24 | $70.4M | $238.4M | ||
| Q1 24 | $101.6M | $237.9M |
总债务KALURMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益KALURMD
| Q4 25 | $826.1M | $6.3B | ||
| Q3 25 | $806.1M | $6.1B | ||
| Q2 25 | $776.0M | $6.0B | ||
| Q1 25 | $756.8M | $5.5B | ||
| Q4 24 | $743.1M | $5.3B | ||
| Q3 24 | $729.4M | $5.2B | ||
| Q2 24 | $727.6M | $4.9B | ||
| Q1 24 | $714.7M | $4.6B |
总资产KALURMD
| Q4 25 | $2.6B | $8.5B | ||
| Q3 25 | $2.6B | $8.3B | ||
| Q2 25 | $2.5B | $8.2B | ||
| Q1 25 | $2.4B | $7.6B | ||
| Q4 24 | $2.4B | $7.1B | ||
| Q3 24 | $2.3B | $7.2B | ||
| Q2 24 | $2.3B | $6.9B | ||
| Q1 24 | $2.3B | $6.8B |
负债/权益比KALURMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.6M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $-51.1M | $311.2M |
| 自由现金流率自由现金流/营收 | -5.5% | 21.9% |
| 资本支出强度资本支出/营收 | 3.3% | 2.0% |
| 现金转化率经营现金流/净利润 | -0.73× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $-25.5M | $1.8B |
8季度趋势，按日历期对齐
经营现金流KALURMD
| Q4 25 | $-20.6M | $339.7M | ||
| Q3 25 | $59.1M | $457.3M | ||
| Q2 25 | $15.9M | $538.8M | ||
| Q1 25 | $57.0M | $578.7M | ||
| Q4 24 | $43.4M | $308.6M | ||
| Q3 24 | $34.1M | $325.5M | ||
| Q2 24 | $26.3M | $440.1M | ||
| Q1 24 | $63.3M | $402.0M |
自由现金流KALURMD
| Q4 25 | $-51.1M | $311.2M | ||
| Q3 25 | $34.5M | $414.4M | ||
| Q2 25 | $-27.7M | $508.2M | ||
| Q1 25 | $18.8M | $557.9M | ||
| Q4 24 | $-12.6M | $288.0M | ||
| Q3 24 | $-17.0M | $307.7M | ||
| Q2 24 | $-17.4M | $415.2M | ||
| Q1 24 | $33.3M | $380.8M |
自由现金流率KALURMD
| Q4 25 | -5.5% | 21.9% | ||
| Q3 25 | 4.1% | 31.0% | ||
| Q2 25 | -3.4% | 37.7% | ||
| Q1 25 | 2.4% | 43.2% | ||
| Q4 24 | -1.6% | 22.5% | ||
| Q3 24 | -2.3% | 25.1% | ||
| Q2 24 | -2.2% | 33.9% | ||
| Q1 24 | 4.5% | 31.8% |
资本支出强度KALURMD
| Q4 25 | 3.3% | 2.0% | ||
| Q3 25 | 2.9% | 3.2% | ||
| Q2 25 | 5.3% | 2.3% | ||
| Q1 25 | 4.9% | 1.6% | ||
| Q4 24 | 7.3% | 1.6% | ||
| Q3 24 | 6.8% | 1.5% | ||
| Q2 24 | 5.7% | 2.0% | ||
| Q1 24 | 4.1% | 1.8% |
现金转化率KALURMD
| Q4 25 | -0.73× | 0.87× | ||
| Q3 25 | 1.50× | 1.31× | ||
| Q2 25 | 0.69× | 1.42× | ||
| Q1 25 | 2.64× | 1.59× | ||
| Q4 24 | 2.19× | 0.90× | ||
| Q3 24 | 3.88× | 1.05× | ||
| Q2 24 | 1.39× | 1.51× | ||
| Q1 24 | 3.48× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KALU
| Packaging | $440.6M | 47% |
| Aero Hs Products | $213.0M | 23% |
| Transferred Over Time | $200.2M | 22% |
| Automotive Extrusions | $75.4M | 8% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
